SCHEMBL6662701

SCHEMBL6662701

CC(C)(C)OC(=O)NCC(=O)OCCCNc1ccc(O)c2c1C(=O)c1c(O)cccc1C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.43
CA12 O43570 5/20 0.39
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
CA9 Q16790 5/20 0.39
MALT1 Q9UDY8 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
MEN1 O00255 3/20 0.37
BLM P54132 3/20 0.37
KMT2A Q03164 3/20 0.37
NSD2 O96028 3/20 0.37
USP2 O75604 2/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 2/20 0.37
MAPK1 P28482 2/20 0.37
RECQL P46063 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
EGFR P00533 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6665635 0.93 MALT1 (0.45) CYP19A1CA12CA1CA2CA9
SCHEMBL6663398 0.85 EGFR (0.48) CA12CA1CA2CA9MALT1
SCHEMBL6664496 0.85 CYP19A1 (0.41) CYP19A1CA2MALT1MEN1BLM
SCHEMBL6663857 0.83 EGFR (0.47) CA12CA1CA2CA9MALT1
SCHEMBL6666935 0.82 MAPT (0.45) CA12CA1CA2CA9MALT1
SCHEMBL6660597 0.79 MALT1 (0.51) MALT1DDB1CRBNMEN1BLM
Trifluoroacetic Acid SCHEMBL6661290 0.79 CYP19A1 (0.45) CYP19A1MEN1BLMKMT2ANSD2
SCHEMBL6663526 0.79 CYP19A1 (0.42) CYP19A1CA12CA1CA2CA9
SCHEMBL6660074 0.79 CYP19A1 (0.41) CYP19A1CA2MALT1MEN1BLM
SCHEMBL6667827 0.76 TLR2 (0.42) CYP19A1CA2MALT1MEN1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296971-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2003-04-02 EP claimed
WO-2001081332-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2001-11-01 WO claimed
EP-1087935-B1 ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS BTG INT LTD (GB) 2004-08-18 EP disclosed